— Know what they know.
Not Investment Advice
Also trades as: FDC.NS (NSE) · $vol 0M

FDC.BO BSE

FDC Limited
1W: -1.8% 1M: -1.2% 3M: -4.2% YTD: -8.3% 1Y: -10.4% 3Y: +46.8% 5Y: +25.0%
₹373.80 ($3.91)
+11.40 (+3.15%)
 
Weekly Expected Move ±3.0%
₹347 ₹358 ₹369 ₹380 ₹391
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 41 · ₹60.8B mcap · 49M float · 0.011% daily turnover
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹60.8B ($635.4M)
52W Range314.75-528.3
Volume8,748
Avg Volume5,223
Beta0.15
Dividend₹5.00
Analyst Ratings
No analyst coverage
Company Info
CEOAmeya Ashok Chandavarkar
Employees6,659
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-01-03
C/3, Skyvistas
Mumbai 400053
IN
91 22 2673 9100
About FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Ziglim Plus 2, Vitcofol, Pyrimon DF, Zocon, Zoxan, Zathrin, Zipod, Amodep-AT, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Electral, Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. The company was founded in 1936 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms